Voyager Therapeutics (VYGR) Misses Q2 EPS by 4c

Voyager Therapeutics (NASDAQ: VYGR) reported Q2 EPS of ($0.57), $0.04 worse than the analyst estimate of ($0.53). Revenue for the quarter came in at $5.2 million versus the consensus estimate of $9.5 million.

For earnings history and earnings-related data on Voyager Therapeutics (VYGR) click here.

You May Also Be Interested In

• TikTok owner ByteDance said to secure $29.6bn loan for AI push
• Sodexo (SW:FP) (SDXAY) PT Raised to EUR58.60 at Bernstein SocGen Group
• Mama's Creations, Inc. (MAMA) Tops Q3 EPS by 1c